Numerous cell line studies have demonstrated a clear link between estrogen receptor overexpression and decreased angiogenic stimulation and, ultimately, improved prognosis [29,30], and another pre-clinical study of cervical cancer cells determined that estrogen receptor-1 loss promoted cancer invasion [31]. Here, ESR1 is linked to cancer.